Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update

被引：0
|
作者：
Gupta, Shilpa
Weight, Christopher J.
Agarwal, Neeraj
Gupta, Sumati
Konety, Badrinath
Gibb, Ewan
Davicioni, Elai
Thyagarajan, Bharat
Sonpavde, Guru
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Univ Utah, Salt Lake City, UT USA
[3] GenomeDx Biosci, Vancouver, BC, Canada
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A008
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer
    Makrakis, Dimitrios
    Wright, Jonathan L.
    Roudier, Martine P.
    Garcia, Jose
    Vakar-Lopez, Funda
    Porter, Michael P.
    Wang, Yan
    Dash, Atreya
    Lin, Daniel
    Schade, George
    Winters, Brian
    Zhang, Xiotun
    Nelson, Peter
    Mostaghel, Elahe
    Cheng, Heather H.
    Schweizer, Michael
    Holt, Sarah K.
    Gore, John L.
    Yu, Evan Y.
    Lam, Hung Ming
    Montgomery, Bruce
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 265 - 272
  • [32] Management of muscle-invasive bladder cancer: an update
    Mohamed A Ghoneim
    Hassan Abol-Enein
    Nature Clinical Practice Urology, 2008, 5 : 501 - 508
  • [33] Management of muscle-invasive bladder cancer: an update
    Ghoneim, Mohamed A.
    Abol-Enein, Hassan
    NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (09): : 501 - 508
  • [34] Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer
    Einerhand, Sarah M. H.
    Black, Anna J.
    Zargar, Homayoun
    Fairey, Adrian S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobson, Niels-Erik
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Xylinas, Evanguelos
    Kassouf, Wassim
    Dall'Era, Marc A.
    Sridhar, Srikala S.
    McGrath, Jonathan S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Grivas, Petros
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    Daneshmand, Siamak
    Zargar-Shoshtari, Kamran
    Spiess, Philippe E.
    van Rhijn, Bas W. G.
    Black, Peter C.
    Mertens, Laura S.
    WORLD JOURNAL OF UROLOGY, 2022, 40 (11) : 2707 - 2715
  • [35] Neoadjuvant nivolumab (N) plus /- ipilimumab (I) in cisplatin-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC).
    Guercio, Brendan John
    Pietzak, Eugene J.
    Brown, Samantha
    Chen, Jie-Fu
    Peters, Vanessa
    Regazzi, Ashley Marie
    Aggen, David Henry
    Donahue, Timothy F.
    Goh, Alvin C.
    Cha, Eugene K.
    Donat, S. Machele
    Dalbagni, Guido
    Bochner, Bernard H.
    Funt, Samuel Aaron
    Bajorin, Dean F.
    Iyer, Gopa
    Ostrovnaya, Irina
    Al-Ahmadie, Hikmat A.
    Rosenberg, Jonathan E.
    Teo, Min Yuen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [36] Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Balar, Arjun Vasant
    Iyer, Gopa
    Apolo, Andrea Borghese
    Regazzi, Ashley Marie
    Garcia-Grossman, Ilana Rebecca
    Pendse, Deepa
    Ostrovnaya, Irina
    Chou, Joanne F.
    Bochner, Bernard
    Dalbagni, Guido
    Herr, Harry W.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] A phase II clinical trial of toripalimab combined with cisplatin plus gemcitabine chemotherapy as neoadjuvant treatment for muscle-invasive bladder cancer
    Yang, Rong
    Li, Tianhang
    Zhang, Shun
    Zhang, Shiwei
    Guo, Hongqian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [38] Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial
    Funt, Samuel A.
    Lattanzi, Michael
    Whiting, Karissa
    Al-Ahmadie, Hikmat
    Quinlan, Colleen
    Teo, Min Yuen
    Lee, Chung-Han
    Aggen, David
    Zimmerman, Danielle
    McHugh, Deaglan
    Apollo, Arlyn
    Durdin, Trey D.
    Truong, Hong
    Kamradt, Jeffrey
    Khalil, Maged
    Lash, Bradley
    Ostrovnaya, Irina
    McCoy, Asia S.
    Hettich, Grace
    Regazzi, Ashley
    Jihad, Marwah
    Ratna, Neha
    Boswell, Abigail
    Francese, Kaitlyn
    Yang, Yuanquan
    Folefac, Edmund
    Herr, Harry W.
    Donat, S. Machele
    Pietzak, Eugene
    Cha, Eugene K.
    Donahue, Timothy F.
    Goh, Alvin C.
    Huang, William C.
    Bajorin, Dean F.
    Iyer, Gopa
    Bochner, Bernard H.
    Balar, Arjun V.
    Mortazavi, Amir
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1312 - +
  • [39] Editorial Comment to "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer"
    Kikuchi, Eiji
    Hayakawa, Nozomi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1106 - 1106
  • [40] Editorial Comment on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer"
    Urabe, Fumihiko
    Suzuki, Hirotaka
    Iwatani, Kosuke
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1107 - 1107
12345